ID   ALAT2_HUMAN             Reviewed;         523 AA.
AC   Q8TD30; Q8N9E2;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   12-APR-2017, entry version 122.
DE   RecName: Full=Alanine aminotransferase 2;
DE            Short=ALT2;
DE            EC=2.6.1.2;
DE   AltName: Full=Glutamate pyruvate transaminase 2;
DE            Short=GPT 2;
DE   AltName: Full=Glutamic--alanine transaminase 2;
DE   AltName: Full=Glutamic--pyruvic transaminase 2;
GN   Name=GPT2; Synonyms=AAT2, ALT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Adipose tissue;
RX   PubMed=11863375; DOI=10.1006/geno.2002.6722;
RA   Yang R.-Z., Blaileanu G., Hansen B.C., Shuldiner A.R., Gong D.-W.;
RT   "cDNA cloning, genomic structure, chromosomal mapping, and functional
RT   expression of a novel human alanine aminotransferase.";
RL   Genomics 79:445-450(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   INVOLVEMENT IN MRT49, VARIANT MRT49 ARG-153, AND CHARACTERIZATION OF
RP   VARIANT MRT49 ARG-153.
RX   PubMed=25758935; DOI=10.1007/s10545-015-9824-x;
RA   Celis K., Shuldiner S., Haverfield E.V., Cappell J., Yang R.,
RA   Gong D.W., Chung W.K.;
RT   "Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2)
RT   causes developmental encephalopathy.";
RL   J. Inherit. Metab. Dis. 38:941-948(2015).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 49-523 IN COMPLEX WITH
RP   PYRIDOXAL PHOSPHATE, AND COFACTOR.
RG   Structural genomics consortium (SGC);
RT   "Human glutamate pyruvate transaminase 2.";
RL   Submitted (AUG-2009) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the reversible transamination between alanine
CC       and 2-oxoglutarate to form pyruvate and glutamate.
CC       {ECO:0000269|PubMed:11863375}.
CC   -!- CATALYTIC ACTIVITY: L-alanine + 2-oxoglutarate = pyruvate + L-
CC       glutamate. {ECO:0000269|PubMed:11863375}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|Ref.7};
CC   -!- PATHWAY: Amino-acid degradation; L-alanine degradation via
CC       transaminase pathway; pyruvate from L-alanine: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TD30-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TD30-2; Sequence=VSP_020008;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in muscle, adipose
CC       tissue, kidney and brain and at lower levels in the liver and
CC       breast. {ECO:0000269|PubMed:11863375}.
CC   -!- DISEASE: Mental retardation, autosomal recessive 49 (MRT49)
CC       [MIM:616281]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. MRT49 patients show a
CC       developmental encephalopathy characterized by rapid onset of
CC       failure to thrive and microcephaly, as well as profoundly delayed
CC       development. {ECO:0000269|PubMed:25758935}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. Alanine aminotransferase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY029173; AAK31794.2; -; mRNA.
DR   EMBL; AK094971; BAC04465.1; -; mRNA.
DR   EMBL; AC018845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062555; AAH62555.1; -; mRNA.
DR   CCDS; CCDS10725.1; -. [Q8TD30-1]
DR   CCDS; CCDS45478.1; -. [Q8TD30-2]
DR   RefSeq; NP_001135938.1; NM_001142466.2. [Q8TD30-2]
DR   RefSeq; NP_597700.1; NM_133443.3. [Q8TD30-1]
DR   UniGene; Hs.460693; -.
DR   PDB; 3IHJ; X-ray; 2.30 A; A=49-523.
DR   PDBsum; 3IHJ; -.
DR   ProteinModelPortal; Q8TD30; -.
DR   SMR; Q8TD30; -.
DR   BioGrid; 124217; 14.
DR   IntAct; Q8TD30; 3.
DR   STRING; 9606.ENSP00000345282; -.
DR   DrugBank; DB00160; L-Alanine.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; Q8TD30; -.
DR   PhosphoSitePlus; Q8TD30; -.
DR   BioMuta; GPT2; -.
DR   DMDM; 74730602; -.
DR   EPD; Q8TD30; -.
DR   MaxQB; Q8TD30; -.
DR   PaxDb; Q8TD30; -.
DR   PeptideAtlas; Q8TD30; -.
DR   PRIDE; Q8TD30; -.
DR   Ensembl; ENST00000340124; ENSP00000345282; ENSG00000166123. [Q8TD30-1]
DR   Ensembl; ENST00000440783; ENSP00000413804; ENSG00000166123. [Q8TD30-2]
DR   GeneID; 84706; -.
DR   KEGG; hsa:84706; -.
DR   UCSC; uc002eel.4; human. [Q8TD30-1]
DR   CTD; 84706; -.
DR   DisGeNET; 84706; -.
DR   GeneCards; GPT2; -.
DR   HGNC; HGNC:18062; GPT2.
DR   HPA; HPA051514; -.
DR   MalaCards; GPT2; -.
DR   MIM; 138210; gene.
DR   MIM; 616281; phenotype.
DR   neXtProt; NX_Q8TD30; -.
DR   OpenTargets; ENSG00000166123; -.
DR   PharmGKB; PA28948; -.
DR   eggNOG; KOG0258; Eukaryota.
DR   eggNOG; COG0436; LUCA.
DR   GeneTree; ENSGT00650000093331; -.
DR   HOGENOM; HOG000215020; -.
DR   HOVERGEN; HBG026148; -.
DR   InParanoid; Q8TD30; -.
DR   KO; K00814; -.
DR   OMA; NEAKAYC; -.
DR   OrthoDB; EOG091G0PY3; -.
DR   PhylomeDB; Q8TD30; -.
DR   TreeFam; TF300839; -.
DR   BioCyc; MetaCyc:HS09332-MONOMER; -.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   UniPathway; UPA00528; UER00586.
DR   ChiTaRS; GPT2; human.
DR   EvolutionaryTrace; Q8TD30; -.
DR   GenomeRNAi; 84706; -.
DR   PRO; PR:Q8TD30; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000166123; -.
DR   CleanEx; HS_GPT2; -.
DR   ExpressionAtlas; Q8TD30; baseline and differential.
DR   Genevisible; Q8TD30; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0004021; F:L-alanine:2-oxoglutarate aminotransferase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; IDA:UniProtKB.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0042853; P:L-alanine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042851; P:L-alanine metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminotransferase;
KW   Complete proteome; Disease mutation; Mental retardation;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   CHAIN         1    523       Alanine aminotransferase 2.
FT                                /FTId=PRO_0000247532.
FT   MOD_RES     341    341       N6-(pyridoxal phosphate)lysine.
FT   MOD_RES     415    415       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BGT5}.
FT   MOD_RES     505    505       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BGT5}.
FT   MOD_RES     512    512       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BGT5}.
FT   VAR_SEQ       1    100       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020008.
FT   VARIANT     153    153       S -> R (in MRT49; loss of function
FT                                mutation; dbSNP:rs786203999).
FT                                {ECO:0000269|PubMed:25758935}.
FT                                /FTId=VAR_073379.
FT   CONFLICT    284    284       D -> G (in Ref. 4; BAC04465).
FT                                {ECO:0000305}.
FT   STRAND       49     52       {ECO:0000244|PDB:3IHJ}.
FT   TURN         53     56       {ECO:0000244|PDB:3IHJ}.
FT   STRAND       57     64       {ECO:0000244|PDB:3IHJ}.
FT   HELIX        67     80       {ECO:0000244|PDB:3IHJ}.
FT   STRAND       86     89       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       107    117       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       119    123       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      125    127       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       129    141       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       157    170       {ECO:0000244|PDB:3IHJ}.
FT   TURN        171    173       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       178    180       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      181    186       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       187    198       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       203    205       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      206    214       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       218    225       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      229    234       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       237    239       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       245    255       {ECO:0000244|PDB:3IHJ}.
FT   TURN        256    258       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      259    269       {ECO:0000244|PDB:3IHJ}.
FT   TURN        271    273       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       279    292       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      295    299       {ECO:0000244|PDB:3IHJ}.
FT   TURN        301    304       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       316    322       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       325    328       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      333    342       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      347    349       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      352    358       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       361    373       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       379    388       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       399    425       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      437    441       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       449    457       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       462    474       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       481    483       {ECO:0000244|PDB:3IHJ}.
FT   STRAND      492    496       {ECO:0000244|PDB:3IHJ}.
FT   HELIX       501    521       {ECO:0000244|PDB:3IHJ}.
SQ   SEQUENCE   523 AA;  57904 MW;  4DD87814C62C7DEA CRC64;
     MQRAAALVRR GCGPRTPSSW GRSQSSAAAE ASAVLKVRPE RSRRERILTL ESMNPQVKAV
     EYAVRGPIVL KAGEIELELQ RGIKKPFTEV IRANIGDAQA MGQQPITFLR QVMALCTYPN
     LLDSPSFPED AKKRARRILQ ACGGNSLGSY SASQGVNCIR EDVAAYITRR DGGVPADPDN
     IYLTTGASDG ISTILKILVS GGGKSRTGVM IPIPQYPLYS AVISELDAIQ VNYYLDEENC
     WALNVNELRR AVQEAKDHCD PKVLCIINPG NPTGQVQSRK CIEDVIHFAW EEKLFLLADE
     VYQDNVYSPD CRFHSFKKVL YEMGPEYSSN VELASFHSTS KGYMGECGYR GGYMEVINLH
     PEIKGQLVKL LSVRLCPPVS GQAAMDIVVN PPVAGEESFE QFSREKESVL GNLAKKAKLT
     EDLFNQVPGI HCNPLQGAMY AFPRIFIPAK AVEAAQAHQM APDMFYCMKL LEETGICVVP
     GSGFGQREGT YHFRMTILPP VEKLKTVLQK VKDFHINFLE KYA
//
